Searched for
FDC
Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...- ORS sales melt in March after govt's stricter labelling normsIndia’s oral rehydration solution (ORS) market has declined after regulatory action restricted the labelling of sugary drinks as ORS, affec...
- USFDA issues Form-483 with 5 observations to Ajanta Pharma's Paithan facilityAjanta Pharma said the US FDA has issued Form-483 with five observations after inspecting its Paithan manufacturing facility in Maharashtra...
- Govt bans anti-cold fixed drug combination for under-four childrenThe matter was deliberated in the Subject Expert Committee (SEC- Pulmonary) meeting held on June 6. "The committee recommended that the FDC...
- Stock Radar: FDC hit fresh 52-week high in June; time to buy more or book profits?Experts predict that FDC, a pharmaceutical company, may reach Rs 400 in the medium term, provided the stock closes above strong resistance ...
- Buy FDC, target price Rs 375: Centrum BrokingFDC Ltd., incorporated in the year 1940, is a Mid Cap company (having a market cap of Rs 4600.69 Crore) operating in Pharmaceuticals sector.
- Stock recommendations: Buy FDC, target price Rs 322: Anand RathiFDC Ltd. key Products/Revenue Segments include Formulations, Bulk Drugs, Export Incentives, Other Operating Revenue for the year ending 31-...
- FDC launches Favipiravir oral suspension to treat COVID-19 in IndiaIn order to combat COVID-19, we believe in offering best efficacy along with convenience to our patients and as such we have focused our ef...
- FDC launches stronger versions of its generic Covid drug, Favipiravir, in IndiaThese prescription-only drugs will be available at all retail medical outlets and hospital pharmacies across the country, from November 1, ...
- FDC launches 2 variants of Favipiravir in India at Rs 55 per tabletNew Delhi, Aug 25 () Drug firm FDC Ltd on Tuesday said it has launched two variants of the COVID-19 drug Favipiravir under the brand names ...
- Add FDC, target Rs 180: Centrum BrokingFDC is a smallcap company, operating in pharmaceuticals and health care sector.
- Buy FDC with a target of Rs 272: Ashwani Gujral"FDC is a 'BUY' call with a target of Rs 272 and a stop loss of Rs 248."
- Buy FDC Ltd with a target of Rs 272: Ashwani Gujral"FDC Ltd is a 'BUY' call with a target of Rs 272 and a stop loss of Rs of 249."
- Buy FDC with a target of Rs 254: Ashwani Gujral"FDC is a 'BUY' call with a target of Rs 254 and a stop loss of Rs of 240"
- Buy FDC with a target of Rs 94: Sandeep Wagle"FDC is a 'BUY' call with a target of Rs 157 and a stop loss of Rs 138."
- Buy FDC with a target of Rs 152: Sandeep Wagle'FDC is a 'BUY' call with a target of Rs 152 and a stop loss of Rs 135.'
- Buy FDC Ltd with a target of Rs 155: Sandeep WagleFDC Ltd is a ‘BUY’ call with a target of Rs 155 and a stop loss of Rs 134.
- FDC promoters plan to sell 67% stake; stock hits 52-week highFDC surged over 14% to hit a 52-week high of Rs 105.95 on reports that the promoters of the pharma firm, plan to sell their 67% stake in th...
- Heard on the Street: FDC stock jumps 13% on promoter stake sale talkPromoters hold 66.9% stake in the company, which owns popular brands such as the electrolyte substitute ‘Electral’.
- Buy FDC for target of Rs 115: APTARTBuy FDC in the range of Rs 103-100 with stoploss of Rs 98 for target of Rs 115.
Load More
